Akso Health Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Akso Health Group generated cash of $1,351,240, which is more than the previous year. Cash used in financing activities reached the amount of $131,653,697 last year. Net change in cash is therefore $77,011,691.
Cash Flow
| 2015 | 2.58M | -223.99K | -1.41M |
|---|---|---|---|
| 2016 | 7.02M | -120.46K | 243.26K |
| 2017 | 8.18M | -287.76K | 4.28M |
| 2018 | 87.72M | -27.62M | 47.51M |
| 2019 | -1.73M | -68.10M | -29.37K |
| 2020 | -55.86M | 12.77M | -3.96M |
| 2021 | 10.05M | -662 | -9.03M |
| 2022 | -8.62M | -19.96M | 34.78M |
| 2023 | -3.25M | 18.47M | -27.51M |
| 2024 | 1.35M | -54.72M | 131.65M |
HX Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.19M | 21.92M | 15.12M | 10.92M | 57.37M | 132.62M | 19.23M | 7.81M | 954.68K | 0 |
Operating activities | ||||||||||
Net income | -9.11M | -13.08M | -16.84M | -34.71M | -71.19M | 5.53M | 65.51M | 8.57M | 3.53M | -350.17K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 18.39K | 15.16K | 580.50K | 406.79K | 174.38K | 92.22K | 61.39K | 19.70K |
Stock-based compensation expense | 0 | 0 | 391.62K | 55.46K | 347.46K | 6.58M | 1.82M | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 391.62K | 55.46K | 347.46K | 6.58M | 1.82M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 327.18K | -8.09M | 13.89K | -25.42K | -183.91K | -418.63K | 0 | 0 | 0 | 0 |
Inventories | 1.49M | 6.10M | -7.79M | 20.51M | 176.6K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 166.04K | 712.88K | -104.24K | -82.09K | -176.6K | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 1.35M | -3.25M | -8.62M | 10.05M | -55.86M | -1.73M | 87.72M | 8.18M | 7.02M | 2.58M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -14.59M | -16.50M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -4.86K | 0 | -314.52K | -944.81K | -456.03K | -287.76K | -120.46K | -223.99K |
Acquisitions Net | 0 | 0 | 0 | 0 | 7.81K | 5.9K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -54.72M | 18.47M | -19.96M | -662 | 12.77M | -68.10M | -27.62M | -287.76K | -120.46K | -223.99K |
Financing activities | ||||||||||
Common Stock Issued | 139.33M | 0 | 10.01M | 4 | 281.61K | 0 | 43.27M | 2M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -19.54M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -2.66M | -1.32M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -10M | -10M | 0 | 20M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 131.65M | -27.51M | 34.78M | -9.03M | -3.96M | -29.37K | 47.51M | 4.28M | 243.26K | -1.41M |
Net Change In Cash | 77.01M | -12.73M | 6.79M | 4.20M | -46.44M | -75.25M | 113.39M | 11.41M | 6.86M | 954.68K |
Cash at end of period | 86.20M | 9.19M | 21.92M | 15.12M | 10.92M | 57.37M | 132.62M | 19.23M | 7.81M | 954.68K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |